US Stock MarketDetailed Quotes

Lunai Bioworks (LNAI)

Watchlist
  • 2.260
  • -0.030-1.31%
Close Jun 10 16:00 ET
  • 2.169
  • -0.091-4.01%
Post 18:09 ET
10.25MMarket Cap-0.04P/E (TTM)

About Lunai Bioworks Company

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Company Profile

SymbolLNAI
Company NameLunai Bioworks
Listing DateDec 10, 2018
ISINUS29350E2037
Founded2011
CEOMr. David Weinstein
MarketNASDAQ
Employees29
Fiscal Year Ends06-30
Address2080 Century Park East,Suite 906
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90067
Phone1-305-918-1980

Company Executives

  • Name
  • Position
  • Salary
  • David Weinstein
  • Chief Executive Officer and Director
  • 1.17M
  • Nathen Fuentes, C.P.A.
  • Chief Financial Officer and Principal Accounting Officer
  • 290.69K
  • James A. Mcnulty, C.P.A.
  • Director
  • 127.16K
  • Douglas W. Calder
  • Director
  • 123.32K
  • Dr. Mark A. Collins, PhD
  • Director
  • 115.76K
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Tensions in the Middle East continue to escalate. After Iran shot down a U.S. Apache helicopter, American forces launched retaliatory airstr Show More